Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spacelabs Medical

This article was originally published in The Gray Sheet

Executive Summary

Coverage, billing and claims processing instructions for ambulatory blood pressure monitoring (ABPM) for Medicare beneficiaries with suspected "white coat" hypertension recently issued to intermediaries by CMS will be effective April 1, the patient monitoring firm announces Jan. 7. Applicable health care common procedure coding system (HCPCS) codes have already been established, according to Spacelabs. CMS issued a favorable coverage decision for the treatment Oct. 17. As a result of coverage, Spacelabs anticipates $30-50 mil. in incremental revenues for its Ultralite ABPM monitor over the next five years (1"The Gray Sheet" Oct. 29, 2001, p. 23). Pricing will be set by local Medicare contractors until CMS issues a national payment amount under the physician fee schedule...

Related Content

UsernamePublicRestriction

Register

MT015953

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel